Bilateral orchidectomy in three metastatic prostate cancer patients with failed LHRH-agonist therapy. - Suppr | 超能文献

Bilateral orchidectomy in three metastatic prostate cancer patients with failed LHRH-agonist therapy.

作者信息

Olapade-Olaopa E O, Oluwasola A O, Shonibare A, Falebita O A, Akang E E, Shokunbi M T

出版信息

S Afr Med J. 2006 Sep;96(9):810-1.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Bilateral orchidectomy in three metastatic prostate cancer patients with failed LHRH-agonist therapy.

S Afr Med J. 2006 Sep;96(9):810-1.

2

Resistance to gonadotropin-releasing hormone agonist in a patient with metastatic prostate cancer.一名转移性前列腺癌患者对促性腺激素释放激素激动剂产生耐药性。

South Med J. 1997 Apr;90(4):460-1. doi: 10.1097/00007611-199704000-00025.

3

Equivalent and sufficient effects of leuprolide acetate and goserelin acetate to suppress serum testosterone levels in patients with prostate cancer.醋酸亮丙瑞林和醋酸戈舍瑞林在抑制前列腺癌患者血清睾酮水平方面具有等效且充分的效果。

BJU Int. 2008 May;101(9):1096-100. doi: 10.1111/j.1464-410X.2007.07374.x. Epub 2008 Jan 8.

4

Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer.在淋巴结阳性前列腺癌男性患者中，根治性前列腺切除术和盆腔淋巴结清扫术后立即进行激素治疗与观察的比较。

N Engl J Med. 1999 Dec 9;341(24):1781-8. doi: 10.1056/NEJM199912093412401.

5

Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.针对雄激素非依赖性前列腺癌的促卵泡激素（FSH）：阿巴瑞克用于睾丸切除术后进展的前列腺癌

Urology. 2004 Feb;63(2):342-7. doi: 10.1016/j.urology.2003.09.045.

6

Prognostic significance of tissue prostate-specific antigen in endocrine-treated prostate carcinomas.组织前列腺特异性抗原在内分泌治疗的前列腺癌中的预后意义。

Clin Cancer Res. 2000 Jan;6(1):160-5.

7

[Diferelin treatment of primary local and generalized cancer of the prostate].

Urologiia. 2001 Nov-Dec(6):17-9.

8

Flutamide versus orchidectomy in the treatment of metastatic prostate carcinoma.氟他胺与睾丸切除术治疗转移性前列腺癌的比较。

Eur Urol. 1997;32(4):391-5; discussion 395-6.

9

Patient treatment preference in metastatic prostate cancer.转移性前列腺癌患者的治疗偏好

Ir Med J. 1996 Jan-Feb;89(1):12.

10

Pulmonary metastases in metastatic prostate cancer: host tissue-tumor cell interactions and response to hormone therapy.转移性前列腺癌的肺转移：宿主组织与肿瘤细胞的相互作用及对激素治疗的反应

Anticancer Res. 1997 May-Jun;17(3A):1517-8.

引用本文的文献

1

Surgical castration efficiently delays the time of starting a systemic chemotherapy in castration-resistant prostate cancer patients refractory to initial androgen-deprivation therapy.手术去势能有效地延缓初始雄激素剥夺治疗耐药的去势抵抗性前列腺癌患者开始全身化疗的时间。

Prostate Int. 2015 Dec;3(4):123-6. doi: 10.1016/j.prnil.2015.10.015. Epub 2015 Oct 20.

2

Surgical castration in hormone-refractory metastatic prostate cancer patients can be an alternative for medical castration.对于激素难治性转移性前列腺癌患者，手术去势可作为药物去势的一种替代方法。

Adv Urol. 2012;2012:979154. doi: 10.1155/2012/979154. Epub 2011 Jun 15.